Andrew Hider is the Chief Executive Officer and President of Baxter International. Andrew has held the CEO seat since August 2025, and was previously CEO at ATS Corporation.
Current company
Baxter International
Baxter International is an American manufacturer of healthcare goods.
medical equipmentHeadquartered in DeerfieldFounded 1931NYSE: BAX
Source: WikidataAndrew Hider has been CEO of Baxter International since August 2025. Before Baxter International, Andrew was CEO at ATS Corporation from March 2017 until August 2025.
Career
Sources: LinkedIn profile
Education
Clarkson University, MBA, MastersClarkson University, BS, Varsity Lacrosse, FraternityMarcellus HSSource
310+ decision makers at Baxter International in Unify, vice president level and above. Choose a function to see who leads it.
Top decision makers at Baxter International
Vice president level and above, most senior firstAndrew Hider leads a leadership team of 5 published executives. The most recent appointment is Maria Cecilia Soriano as Group President, Infusion Therapies & Technologies & Pharmaceuticals, in seat since 2025.
Executive leadership
| Name | Title | In seat since |
|---|---|---|
| Andrew Hider | President and Chief Executive Officer | August 2025 |
| Joel T. Grade | Executive Vice President, Chief Financial Officer | 2023 |
| David S. Rosenbloom | Executive Vice President and General Counsel | Not stated |
| Reazur Rasul | Executive Vice President and Group President, Healthcare Systems & Technologies | 2023 |
| Maria Cecilia Soriano | Group President, Infusion Therapies & Technologies & Pharmaceuticals | 2025 |
Sources: Baxter International 2025 Form 10-K
Andrew Hider is the Chief Executive Officer and President of Baxter International. Andrew has held the CEO seat since August 2025, and was previously CEO at ATS Corporation.
Andrew Hider has been CEO of Baxter International since August 2025, according to LinkedIn profile.
Andrew Hider was CEO at ATS Corporation from March 2017 until August 2025, according to LinkedIn profile.
Andrew Hider has been CEO of Baxter International for 1 year, since August 2025.
Joel T. Grade (Executive Vice President, Chief Financial Officer), David S. Rosenbloom (Executive Vice President and General Counsel), Reazur Rasul (Executive Vice President and Group President, Healthcare Systems & Technologies), Maria Cecilia Soriano (Group President, Infusion Therapies & Technologies & Pharmaceuticals). Source: Baxter International 2025 Form 10-K.
The seat holder is identified in Unify's professional profile dataset, then confirmed against the company's published leadership page, its SEC filings, and Wikipedia before publication. Career and education rows carry the public document they were taken from. Leadership team membership follows the company's own leadership page; in-seat dates come from filings where available and otherwise from the profile record. Company figures are read from the Unify headcount page for the same company and are profile coverage measures, never company-reported workforce totals. The employee preview lists vice president and senior vice president level profiles by department. No personal contact details are published.
